Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilpivirine versus efavirenz with tenofovir + lamivudine in treatment-naive adults with HIV infection on methadone maintenance
ChiCTR-TRC-14004908Phase 4Recruiting
- Sponsor
- Yunnan Provincial Infectious Disease Hospital
- Start
- Jul 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rilpivirine, efavirenz, tenofovir, lamivudine and methadone in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Yunnan Provincial Infectious Disease Hospital. Primary endpoints: HIV RNA, CD4 cell count and 4 more. Started Jul 2014; status: recruiting.
02
Drugs
rilpivirineefavirenztenofovirlamivudinemethadone
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR-TRC-14004908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004908.